| Classified by tertile of SD of HbA1c | Classified by tertile of SD of FPG | ||||||
---|---|---|---|---|---|---|---|---|
First tertile group (n = 79) | Second tertile group (n = 80) | Third tertile group (n = 80) | P value | First tertile group (n = 79) | Second tertile group (n = 80) | Third tertile group (n = 80) | P value | |
Age (year)a | 65.97 ± 5.52 | 64.36 ± 7.30 | 64.88 ± 5.74 | 0.253 | 65.27 ± 6.09 | 64.71 ± 6.08 | 65.23 ± 6.62 | 0.825 |
Sex, female (%)b | 36 (45.57) | 42 (52.50) | 47 (58.75) | 0.252 | 41 (50.00) | 47 (59.49) | 37 (47.44) | 0.279 |
BMI (kg/m2)a | 24.43 ± 2.94 | 23.58 ± 2.71 | 23.79 ± 2.81 | 0.147 | 23.89 ± 2.89 | 23.44 ± 2.75 | 24.46 ± 2.79 | 0.074 |
SBP (mm Hg)a | 152.92 ± 11.85 | 153.01 ± 8.71 | 156.02 ± 8.99 | 0.083 | 152.35 ± 8.16 | 153.56 ± 9.70 | 156.03 ± 11.61 | 0.061 |
DBP (mm Hg)a | 83.68 ± 9.54 | 80.81 ± 7.73 | 82.92 ± 7.08 | 0.073 | 83.06 ± 8.34 | 82.38 ± 7.35 | 81.96 ± 8.99 | 0.701 |
Heart rate (bpm)a | 74.82 ± 9.65 | 76.01 ± 9.09 | 74.34 ± 8.89 | 0.498 | 74.65 ± 10.78 | 75.30 ± 7.30 | 75.23 ± 9.31 | 0.888 |
Duration of diabetes (years)c | 3.00 (2.85, 3.25) | 3.00 (2.85, 3.27) | 3.00 (2.82, 3.33) | 0.905 | 3.00 (2.90, 3.35) | 3.00 (2.69, 3.13) | 3.00 (2.93, 3.19) | 0.342 |
Current smoking, n (%)b | 8 (10.13) | 9 (11.25) | 7 (8.75) | 0.871 | 8 (9.76) | 8 (10.13) | 8 (10.26) | 0.994 |
Current drinking, n (%)b | 5 (6.33) | 6 (7.50) | 5 (6.25) | 0.940 | 7 (8.54) | 3 (3.80) | 6 (7.69) | 0.442 |
Hypertension history, n (%)b | 62 (78.48) | 60 (75.00) | 65 (81.25) | 0.631 | 64 (78.05) | 61 (77.22) | 62 (79.49) | 0.941 |
FPG (mmol/L)a | 9.80 ± 1.50 | 9.80 ± 1.57 | 10.14 ± 1.54 | 0.269 | 9.97 ± 1.43 | 9.99 ± 1.46 | 9.78 ± 1.72 | 0.625 |
HbA1c (%)a | 10.01 ± 2.00 | 10.17 ± 1.53 | 10.62 ± 1.34 | 0.061 | 10.21 ± 1.44 | 10.19 ± 1.76 | 10.40 ± 1.77 | 0.684 |
TCHO (mmol/L)a | 5.10 ± 0.99 | 5.36 ± 0.96 | 5.39 ± 1.00 | 0.127 | 5.41 ± 0.91 | 5.27 ± 0.96 | 5.18 ± 1.08 | 0.332 |
TG (mmol/L)a | 1.89 ± 1.11 | 1.61 ± 0.84 | 1.73 ± 1.01 | 0.200 | 1.65 ± 0.88 | 1.65 ± 0.88 | 1.92 ± 1.18 | 0.139 |
HDL-c (mmol/L)a | 1.37 ± 0.45 | 1.41 ± 0.48 | 1.38 ± 0.50 | 0.893 | 1.38 ± 0.50 | 1.36 ± 0.41 | 1.42 ± 0.52 | 0.768 |
LDL-c (mmol/L)a | 3.35 ± 1.15 | 3.63 ± 1.11 | 3.67 ± 1.21 | 0.167 | 3.70 ± 1.08 | 3.58 ± 1.03 | 3.38 ± 1.33 | 0.215 |
Hypoglycemic agents, n (%)b | Â | Â | Â | Â | Â | Â | Â | Â |
 Metformin | 73 (92.41) | 72 (90.00) | 75 (93.75) | 0.675 | 74 (90.24) | 74 (93.67) | 72 (92.31) | 0.720 |
 Gliclazide | 39 (49.37) | 34 (42.50) | 35 (43.75) | 0.653 | 37 (45.12) | 36 (45.57) | 35 (44.87) | 0.996 |
 Other sulfonylurea | 24 (30.38) | 21 (26.25) | 22 (27.50) | 0.839 | 22 (26.83) | 18 (22.78) | 27 (34.62) | 0.245 |
 Thiazolidinedione | 7 (8.86) | 5 (6.25) | 8 (10.00) | 0.681 | 11 (13.41) | 4 (5.06) | 5 (6.41) | 0.120 |
 Acarbose | 15 (18.99) | 15 (18.75) | 11 (13.75) | 0.613 | 19 (23.17) | 12 (15.19) | 10 (12.82) | 0.189 |
 Glinide | 4 (5.06) | 4 (5.00) | 3 (3.75) | 0.905 | 5 (6.10) | 4 (5.06) | 2 (2.56) | 0.551 |
 Insulin | 9 (11.39) | 7 (8.75) | 7 (8.75) | 0.809 | 8 (9.76) | 8 (10.13) | 7 (8.97) | 0.969 |
Other drugs, n (%)b | Â | Â | Â | Â | Â | Â | Â | Â |
 Antihypertension drug | 57 (72.15) | 56 (70.00) | 63 (79.63) | 0.425 | 58 (70.73) | 58 (73.42) | 60 (76.92) | 0.673 |
 Aspirin | 56 (70.89) | 49 (61.25) | 43 (53.75) | 0.084 | 51 (62.20) | 47 (59.49) | 50 (64.10) | 0.836 |
 Statins | 11 (13.92) | 13 (16.25) | 11 (13.75) | 0.883 | 12 (14.63) | 12 (15.19) | 11 (14.10) | 0.982 |